Prestige Consumer Healthcare
PBH
#4655
Rank
HK$18.35 B
Marketcap
HK$387.54
Share price
2.62%
Change (1 day)
-38.41%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2025 (TTM): HK$31.40

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is HK$31.60. In 2024 the company made an earnings per share (EPS) of HK$33.72 an increase over its 2023 EPS that were of -HK$12.63.

EPS history for Prestige Consumer Healthcare from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$31.40-6.87%
2024HK$33.72-367.08%
2023-HK$12.63-138.33%
2022HK$32.9411.7%
2021HK$29.4813.6%
2020HK$25.96-651.67%
2019-HK$4.71-148.78%
2018HK$9.65-83.29%
2017HK$57.71437.23%
2016HK$10.74-34.13%
2015HK$16.3152.94%
2014HK$10.66-8.11%
2013HK$11.61
2011HK$6.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.51 116.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
HK$54.81 73.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$55.05 74.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.27-67.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$28.30-10.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
HK$48.46 53.35%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
HK$18.11-42.68%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$30.48-3.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
-HK$232.27-834.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
HK$9.57-69.73%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel